Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria

BACKGROUND: Poor ovarian response (POR) remains one of the most challenging conditions in assisted reproduction technology. Previous studies seemed to indicate that growth hormone (GH) was a potential solution for the dilemma of POR; however, the role GH played on the low-prognosis patients diagnose...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xueying, Xu, Jingxiao, Bi, Lixin, Liu, Peihao, Jiao, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678589/
https://www.ncbi.nlm.nih.gov/pubmed/34925245
http://dx.doi.org/10.3389/fendo.2021.790160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678589/
https://www.ncbi.nlm.nih.gov/pubmed/34925245
http://dx.doi.org/10.3389/fendo.2021.790160

Ejemplares similares